Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EyePoint, Inc.EYPT · Entity 5702 | Chief Financial Officer | August 20, 2026 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EyePoint, Inc.
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 25,000 |
Reported balance
After 2026-08-20 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-20 · Other · Disposed 5,000 · Balance 25,000 F1: On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company from an irrevocable family trust of which JP Morgan Trust Company of Delaware is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust"). F2: These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Direct | 96,691 |
Reported balance
After 2026-08-20 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-20 · Other · Acquired 5,000 · Balance 96,691 F1: On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company from an irrevocable family trust of which JP Morgan Trust Company of Delaware is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust"). |
| Common StockSEC Table I · non-derivative | Direct | 32,517 |
Reported balance
After 2026-08-20 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-08-20 · Gift · Disposed 64,953 · Balance 32,517 F3: On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company to the GEORGE O. ELSTON 2026 GRAT (the "GRAT"), a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary. F4: Includes 779 shares acquired on July 31, 2026, pursuant to EyePoint's 2019 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 64,953 |
Reported balance
After 2026-08-20 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-08-20 · Gift · Acquired 64,953 · Balance 64,953 F3: On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company to the GEORGE O. ELSTON 2026 GRAT (the "GRAT"), a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary. F5: These securities are held in the GRAT, a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company from an irrevocable family trust of which JP Morgan Trust Company of Delaware is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust").
F2: These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3: On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company to the GEORGE O. ELSTON 2026 GRAT (the "GRAT"), a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary.
F4: Includes 779 shares acquired on July 31, 2026, pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
F5: These securities are held in the GRAT, a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2024 Filed Jan 10, 2024 02:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 45,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000397 · primarydocument.xml · derivative · entry 3 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-01-05 F3 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 5, 2025. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:47 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $8.23 | $0.00 |
DisclosureSEC source: 0001562180-23-007325 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-10-15 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remainig thirty-six months Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 13:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 45,855 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005442 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,855 Underlying: Common Stock · 45,855 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:13 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 22,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004579 · primarydocument.xml · derivative · entry 2 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning May 25, 2024. F2 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning May 25, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:13 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001562180-23-004579 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-05-24 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at May 25th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:58 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001331 · primarydocument.xml · derivative · entry 4 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,967 Underlying: Common Stock · 4,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vests in three ratable annual installments beginning February 9, 2023. F2 · derivative.expiration_date: The restricted stock units vests in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:58 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 5,833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001331 · primarydocument.xml · derivative · entry 3 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,667 Underlying: Common Stock · 5,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vests in three ratable annual installments beginning February 9, 2023. F2 · derivative.expiration_date: The restricted stock units vests in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:58 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001331 · primarydocument.xml · nonDerivative · entry 2 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:58 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001331 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 887 shares acquired on 7/31/22 and 2,745 shares acquired on January 31, 2023, pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:53 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 91,655 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000345 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,655 Underlying: Common Stock · 91,655 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · derivative · entry 5 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-02-09 F5 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 17,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · derivative · entry 4 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires not disclosed F4 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F4 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · derivative · entry 3 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,934 Underlying: Common Stock · 4,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F3 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,721 | $10.13 | $17,433.73 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · nonDerivative · entry 2 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001416 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 739 shares acquired on January 29, 2021, 648 shares acquired on July 30, 2021 and 970 shares acquired on January 31, 2022 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:27 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 60,300 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004452 · primarydocument.xml · derivative · entry 2 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,300 Underlying: Common Stock · 60,300 shares Expires 2031-02-09 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:27 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 14,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004452 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,900 Underlying: Common Stock · 14,900 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 13:16 UTC | EyePoint, Inc. EYPT · Entity 5702 | PurchaseCommon Stock | 10,000 | $0.48 | $4,800.00 |
DisclosureSEC source: 0001562180-20-005930 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:21 UTC | EyePoint, Inc. EYPT · Entity 5702 | PurchaseCommon Stock | 10,000 | $0.61 | $6,112.00 |
DisclosureSEC source: 0001562180-20-005659 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| March 12, 2020 Filed Mar 13, 2020 12:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | PurchaseCommon Stock | 10,000 | $0.96 | $9,600.00 |
DisclosureSEC source: 0001562180-20-002451 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:06 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 110,371 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001562180-20-002048 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,371 Underlying: Common Stock · 110,371 shares Expires 2030-02-28 F1 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which begins March 28, 2020 Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 13:42 UTC | EyePoint, Inc. EYPT · Entity 5702 | PurchaseCommon Stock | 10,000 | $1.43 | $14,290.00 |
DisclosureSEC source: 0001562180-19-005548 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 13:42 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Options (Right to buy) · Derivative | 745,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001562180-19-005548 · primarydocument.xml · derivative · entry 2 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745,000 Underlying: Common Stock · 745,000 shares Expires 2029-11-14 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remainig thirty-six months Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.